LIP
ASND icon

Lighthouse Investment Partners’s Ascendis Pharma A/S ASND Stock Holding History

Lighthouse Investment Partners’s Portfolio ASND Stock Details ASND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-10,000
Closed -$1.99M – 884
2025
Q3 		$1.99M Buy
+10,000
New +$1.87M 0.06% 336

Other funds holding ASND

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Lighthouse Investment Partners's ASND Position: Q1 2026 in Review

Lighthouse Investment Partners reduced its Ascendis Pharma A/S (ASND) stake by 53% in Q1 2026, selling an estimated $1.5M and leaving 6,021 shares worth $1.38M. The position accounts for 0.05% of the portfolio, ranked #371.

Lighthouse Investment Partners first reported a position in ASND in Q2 2024 and has held it in 3 quarters since. The position peaked at $2.76M in Q2 2024. 273 funds tracked by Wall St. Rank hold ASND as of Q1 2026.

  • Lighthouse Investment Partners held 6,021 shares of Ascendis Pharma A/S worth $1.38M as of Q1 2026.
  • Lighthouse Investment Partners sold 6,698 Ascendis Pharma A/S shares in Q1 2026, an estimated $1.5M.
  • Ascendis Pharma A/S made up 0.05% of Lighthouse Investment Partners's portfolio in Q1 2026, its #371 holding.
  • Lighthouse Investment Partners first reported a position in Ascendis Pharma A/S in Q2 2024 and has held it in 3 quarters since.
  • Lighthouse Investment Partners's Ascendis Pharma A/S position peaked at $2.76M in Q2 2024.
  • 273 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q1 2026.

Based on Lighthouse Investment Partners's 13F filing for Q1 2026, filed 14 May 2026.